P53 mutations in lung tumours: Relationship to gender and lung DNA adduct levels

被引:140
作者
Kure, EH
Ryberg, D
Hewer, A
Phillips, DH
Skaug, V
Baera, R
Haugen, A
机构
[1] NATL INST OCCUPAT HLTH,DEPT TOXICOL,N-0033 OSLO,NORWAY
[2] INST CANC RES,HADDOW LABS,SECT MOL CARCINOGENESIS,SUTTON SM2 5NG,SURREY,ENGLAND
关键词
D O I
10.1093/carcin/17.10.2201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human lung cancer exhibits a high frequency of transversion mutations at G:C base pairs of the p53 gene, possibly the result of DNA damage by cigarette smoke constituents, most notably benzo[a]pyrene. We have investigated gender differences in the p53 mutational spectrum and levels of hydrophobic DNA adducts. Tumour tissue was obtained from 115 non-small cell lung cancer tumours and examined for mutational alterations in the p53 gene (exons 4-9) using PCR and single-strand conformational polymorphism analysis. We have previously examined exons 5-8 in lung cancer. Sequence analysis of exons 4 and 9 revealed that almost 20% of the mutations were located in exons 4 and 9. The levels of hydrophobic DNA adducts in non-tumorous lung tissue of 55 of the patients Were analyzed by the P-32-postlabelling assay. There were both a higher frequency of G:C-->T:A mutations and a higher average hydrophobic DNA adduct level in females than in male patients, even though the level of exposure to carcinogens from cigarette smoking was lower among the females than among the males, Frameshift mutations were more common in women than in men (30 versus 15%). These preliminary findings lend support to epidemiological evidence that women may be at greater risk than men of contracting tobacco-induced lung cancer.
引用
收藏
页码:2201 / 2205
页数:5
相关论文
共 22 条
  • [1] *CANC REG NORW, 1989, INC CANC NORW 1982 1
  • [2] CHIBA I, 1990, ONCOGENE, V5, P1603
  • [3] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [4] GENOTOXICITY OF TOBACCO-SMOKE AND TOBACCO-SMOKE CONDENSATE
    DEMARINI, DM
    [J]. MUTATION RESEARCH, 1983, 114 (01): : 59 - 89
  • [5] FELIX CA, 1994, ONCOGENE, V9, P327
  • [6] GREENBLATT MS, 1994, CANCER RES, V54, P4855
  • [7] GENDER COMPARISONS IN HUMAN LUNG-CANCER - ANALYSIS OF P53 MUTATIONS, ANTI-P53 SERUM ANTIBODIES AND C-ERBB-2 EXPRESSION
    GUINEE, DG
    TRAVIS, WD
    TRIVERS, GE
    DEBENEDETTI, VMG
    CAWLEY, H
    WELSH, JA
    BENNETT, WP
    JETT, J
    COLBY, TV
    TAZELAAR, H
    ABBONDANZO, SL
    PAIROLERO, P
    TRASTEK, V
    CAPORASO, NE
    LIOTTA, LA
    HARRIS, CC
    [J]. CARCINOGENESIS, 1995, 16 (05) : 993 - 1002
  • [8] *INT AG RES CANC, 1992, IAR SCI PUBL, V120
  • [9] *INT AG RES CANC, 1993, IARC SCI PUBL, V121
  • [10] JEGO N, 1993, ONCOGENE, V8, P209